Erratum: Effects of three months diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (Diabetic Medicine (2000) 17 (518-523))

Erratum: Effects of three months diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (Diabetic Medicine (2000) 17 (518-523))

Bibliographic Details
Main Authors:	Manley, SE, Stratton, I, Cull, C, Frighi, V, Eeley, E, Matthews, DR, Holman, R, Neil, H
Format:	Journal article
Language:	English
Published:	2001

Similar Items

Effects of three months' diet after diagnosis of type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45) (vol 17, pg 518, 2000)
by: Manley, SE, et al.
Published: (2001)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)
by: Manley, SE, et al.
Published: (2000)

Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group.
by: Manley, SE, et al.
Published: (2000)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
by: Turner, R, et al.
Published: (1991)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (1999)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
by: Matthews, DR, et al.
Published: (1998)

Ethnic differences in diabetic nephropathy - The UKPDS
by: Stevens, R, et al.
Published: (1999)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
by: Cull, C, et al.
Published: (1993)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
by: Stratton, I, et al.
Published: (2000)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
by: Turner, R, et al.
Published: (1998)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
by: Matthews, DR, et al.
Published: (1998)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
by: Adler, A, et al.
Published: (2003)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
by: Kohner, E, et al.
Published: (2001)

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
by: Turner, R, et al.
Published: (1998)

UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
by: Eeley, E, et al.
Published: (1996)

UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
by: Eeley, E, et al.
Published: (1996)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
by: Stratton, I, et al.
Published: (2001)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
by: Cull, C, et al.
Published: (2001)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
by: Turner, R, et al.
Published: (1999)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
by: Kothari, V, et al.
Published: (2002)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
by: Cull, C, et al.
Published: (2004)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
by: Levy, J, et al.
Published: (1993)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
by: Levy, J, et al.
Published: (1993)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
by: Stratton, I, et al.
Published: (2006)

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
by: Horton, V, et al.
Published: (1999)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
by: Clarke, P, et al.
Published: (2004)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
by: Gray, A, et al.
Published: (2001)

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
by: Adler, A, et al.
Published: (1999)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
by: Adler, A, et al.
Published: (2000)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
by: Adler, A, et al.
Published: (2005)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
by: Holman, R, et al.
Published: (2001)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
by: Davis, T, et al.
Published: (2005)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
by: Kohner, E, et al.
Published: (1999)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
by: Turner, R, et al.
Published: (1998)

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
by: Mehta, Z, et al.
Published: (1999)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
by: Stevens, R, et al.
Published: (2002)

Risk factors for neuropathy in UKPDS
by: Stratton, I, et al.
Published: (2004)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (2000)